Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 831-834

  Papachristou, E ^a   Link, K H ^b   Schoenberg, M H ^a  

^a Chirurgie ^*  (Germany)

^b Asklepios Paulinen Klinik   (Germany)

Author keywords

Pancreatic cancer; Regional celiac artery influsion

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINATE CALCIUM; FOLINIC ACID; MITOXANTRONE; ONDANSETRON;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; BONE MARROW SUPPRESSION; CANCER SURGERY; CANCER SURVIVAL; CELIAC ARTERY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GASTRITIS; HUMAN; LIVER METASTASIS; MALE; PANCREAS CANCER; PRIORITY JOURNAL; TOXICITY; ULCER; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELIAC ARTERY; CISPLATIN; CYSTADENOCARCINOMA; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; MALE; MIDDLE AGED; MITOXANTRONE; NEOPLASM STAGING; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0037861956     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Beger HG, Büchler MW and Friess H: Chirurgische ergebnisse und indikationen zu adjuvanten massnahmen beim pankreascarcinom. Chirurg 65: 246-252, 1994.
2. Sperti C, Pasquali C, Piccoli A and Pedrazzolli S: Recurrence after resection for ductal adenocarcinorna of the pancreas. World- J Surg 21: 195-200, 1997.
3. Griffin JF, Smallez SR, Jewell W et al.: Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66: 56-61, 1990.
4. Gastrointestinal Tumor Study Group: Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 59: 2006-2010, 1987.
5. Gastrointestinal Tumor Study Group: Treatment of locally resectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst 80: 751-755, 1988.
6. Kalser MH and Ellenberg SS.: Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120: 899-903, 1994.
7. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link KH, Beger HG, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Büchler MW, for the members of The European Study Group for pancreatic cancer. Lancet 358: 1576-85, 2001.
8. Link KH, Gansauge F, Pillasch J, Rilinger N, Büchler M and Beger HG: Regional treatment of advanced nonresectable and of resected pancreatic cancer via celiac axis infusion: First results of a single institution study. Dig Surg 11: 414-419, 1994.
9. Weiss L, Harlos JP, Hartveit F, Maartmann-Moe H, Svendsen E, Christen S, Torhorst J, Home CHW and Johnson SJ: Metastatic pattern from cancers of the pancreas: An analysis of 558 autopsies. Regul Cancer Treat 4: 265-271, 1992.
10. Ettinghausen SE: Rationale for intraperitoneal chemotherapy in the treatment of adenocarcinoma of the pancreas. Regul Cancer Treat 8: 20-24, 1995.
11. Warschaw AL: Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 199 1; 161: 26-30, 1991.
12. Ishikawa O, Ohigashi H, Sasaki Y, Furukawa H, Kabuto T, Kameyama M, Nakamori S, Hiratsuka M and Imaoka S: Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 168: 361-364, 1994.
13. Ohigashi H: Arterial infusion chemotherapy for advanced pancreatic cancer. In: Taguchi T, Nakamura H (eds): Arterial Infusion Chemotherapy. Tokyo, Jpn J Cancer and Chemother Publ Inc., 416-426, 1994.
14. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T and Miyazaki I: An evaluation of radical resection for pancreatic cancer based on the mode of recurrence determined by autopsy and diagnostic imaging. Cancer 72: 2118-2123, 1993.
15. Andren-Sandberg A, Westerdahl J and Ihse I: Recurrence after pancreatectomy of pancreatic cancer. Digestion 52: 67, 1992.
16. Arbuck SG.: Overview of chemotherapy for pancreatic cancer. Int J Pancreatol 7: 209-222, 1990.
17. Abrams RA, Grochow LB, Chakravarthy A et al.: Intensified adjuvant therapy of pancreatic and periampullary adenocarcinoma: survival results and observation regarding patterns of failure, radiotherapy dose and CA 19-9 levels. Int J Radiat Oncol Biol Phys 44: 1039-46, 1999.
18. Heinemann V: Gemcitabine: progress in the treatment of pancreatic cancer. Oncology 60(1): 8-18, 2001.
19. Philip PA, Zalupski MM, Vaitkevicius VK, Arlauskas P, Chaplen R, Heilbrun LE Adsay V, Weaver D and Shields AF: Phase II study of gemcitabine and Cisplatin in the treatment patients with advanced pancreatic carcinoma. Cancer 92(3): 569-771, 2001.
20. Gall FP and Zimgibl H: Maligne tumoren des pankreas und der periampullären region. In: Gall FP, Hermaneck P, Tonak J (eds): Chirurgische Onkologie, Berlii Springer, 1986, pp 416-460.
21. Bakkevold KE, Arnesjo B, Dahl O and Kambstad B: Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater. Results of a controlled, prospective, randomized multicentre study. Eur J Cancer 29A: 698-703, 1993.
22. Foo ML, Gunderson LL, Nagorney DM, Mellrath DC, van Heerden JA, Robinoi JS, Kvols LK, Garton GR, Martenson JA and Cha SS: Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation 5 fluorouracil. Int J Radiat Oncol Biol Phys 26: 483-489, 1993.